Related references
Note: Only part of the references are listed.Characteristics of Japanese inflammatory bowel disease susceptibility loci
Yoshiaki Arimura et al.
JOURNAL OF GASTROENTEROLOGY (2014)
Clinical investigation in highly disease-affected rheumatoid arthritis patients in Japan with adalimumab applying standard and general evaluation: the CHANGE study
Nobuyuki Miyasaka et al.
Modern Rheumatology (2014)
One-year maintenance outcomes among patients with moderately-to-severely active ulcerative colitis who responded to induction therapy with adalimumab: subgroup analyses from ULTRA 2
W. J. Sandborn et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
Extracorporeal Photopheresis (ECP) in Patients with Steroid-dependent Crohn's Disease: An Open-label, Multicenter, Prospective Trial
Walter Reinisch et al.
INFLAMMATORY BOWEL DISEASES (2013)
Adalimumab for the induction and maintenance of clinical remission in Japanese patients with Crohn's disease
Mamoru Watanabe et al.
JOURNAL OF CROHNS & COLITIS (2012)
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management
Axel Dignass et al.
JOURNAL OF CROHNS & COLITIS (2012)
Effects of family history on inflammatory bowel disease characteristics in Japanese patients
Erika Kuwahara et al.
JOURNAL OF GASTROENTEROLOGY (2012)
Update on biologic pathways in inflammatory bowel disease and their therapeutic relevance
Matthew J. Hamilton et al.
JOURNAL OF GASTROENTEROLOGY (2012)
Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial
Walter Reinisch et al.
GUT (2011)
European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease
J. F. Rahier et al.
JOURNAL OF CROHNS & COLITIS (2009)
Prevalence of ulcerative colitis and Crohn's disease in Japan
Keiko Asakura et al.
JOURNAL OF GASTROENTEROLOGY (2009)
The role of TNFα in ulcerative colitis
Bruce E. Sands et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: The CHARM trial
Jean-Frederic Colombel et al.
GASTROENTEROLOGY (2007)
Glucocorticoid use, other associated factors, and the risk of tuberculosis
SS Jick et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2006)
Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial
SB Hanauer et al.
GASTROENTEROLOGY (2006)
Efficacy, pharmacokinetic, and safety assessment of adalimumab, a fully human anti-tumor necrosis factor-alpha monoclonal antibody, in adults with rheumatoid arthritis receiving concomitant methotrexate: A pilot study
MH Weisman et al.
CLINICAL THERAPEUTICS (2003)
Inflammatory bowel disease
DK Podolsky
NEW ENGLAND JOURNAL OF MEDICINE (2002)
The natural history of corticosteroid therapy for inflammatory bowel disease: A population-based study
WA Faubion et al.
GASTROENTEROLOGY (2001)
Share Paper
